Taysha Gene Therapies Inc
NASDAQ:TSHA
Taysha Gene Therapies Inc
NASDAQ:TSHA
Price:
1.655
USD
-2.65%
Market Cap:
339.3m
USD
P/B
Price to Book Value
Price to Book Value
4.7
Current
4.3
Median
2.4
Industry
Higher
than median
Higher
than industry value
Price to Book Value (P/B) ratio is a valuation multiple that measures the market's valuation of a company relative to its book value. The P/B ratio is only considered useful in practice when applied to capital-intensive businesses.
P/B
=4.7
Market Cap
/
339.2m USD
Book Value of Equity
71.5m USD
P/B Forward Multiples
Forward P/B multiple is a version of the P/B ratio that uses forecasted equity for the P/B calculation. 1-Year, 2-Years, and 3-Years forwards use equity forecasts for 1, 2, and 3 years ahead, respectively.
1-Year Forward
P/B
N/A
2-Years Forward
P/B
N/A
3-Years Forward
P/B
N/A
You don't have any saved screeners yet
